Ultrasonic scalpel uses high-speed vibration to denature tissue proteins, a
chieving cutting and hemostatic effects. It effectively reduces bleeding, sh
ortens surgical time, and reduces hospital stays. When using an ultrasonic
scalpel, it does not generate smoke that affects the surgical field of view.
Additionally, the local temperature generated is lower than that of traditio
nal electric scalpels and lasers, resulting in less thermal damage to the tiss
ues. It has a coagulation and sealing effect, effectively coagulating and cut
ting blood vessels with a diameter of less than 3mm, significantly reducin
g the need for traditional sutures, vascular clips, and the risk of leaving for
eign bodies such as suture tails in the body, which can cause inflammatio
n. The damage to surrounding tissues is much more minor than traditiona
l electric cautery, providing precise cutting and hemostatic effects and sig
nificantly reducing the risk of accidental injury to surrounding tissues and
bleeding.
The ultrasonic scalpel does not use traditional monopolar electrosurgery,
eliminating issues such as current passing through the body or erratic curr
ents. It does not stimulate nerves and muscles or affect the nerves around
the pelvic cavity. Therefore, it reduces the side effects of postoperative blo
ating and difficulty urinating with traditional monopolar electrosurgery, al
lowing for a shorter hospital stay and early discharge.
The ultrasonic scalpel device can be widely used in plastic surgery, pediatr
ics, gynecology, urology, orthopedics, general surgery, and many other su
rgical procedures, such as gallbladder removal, appendectomy, gastric an
d liver resection, breast surgery, thyroid surgery, gastrointestinal and hem
orrhoid surgery, as well as other open and endoscopic surgeries.
Maxima Biotech, established in April 2019 with investment from SUMMED Innovation Platform, is dedicated to local development and optimized mass production of advanced minimally invasive medical devices. Our team possesses extensive practical experience in medical device distribution, product development, and innovation licensing. This enables Maxima Biotech to integrate Taiwan's supply chain and advantages, swiftly charting the course for the development of high-end medical equipment. Through continuous innovation, we are committed to meeting the global demand for high-quality medical materials, providing efficient and cost-effective solutions.
AI Clerk Platform:Tool for Automatically Converting Unstructured Medical Chart/Data into Semantic Structured Data
Precision Psychiatry: Quantitative Technology for Tracking Personalized Brain Region Abnormalities Across Disease Progression
Development of a Mesenchymal Stem Cell Platform for Multi-Gene Precision Delivery: A Novel Strategy for Cross-Cancer Precision Immunotherapy
Development of a stiffness-variable robot for wrist rehabilitation using magnetic series elastic actuator
Technology maturity:Mass production
Exhibiting purpose:Display of scientific results、Product promotion
Trading preferences:Technical license/cooperation、New products development、Negotiate by self
*Organization
*Name
*Phone
*Main Purpose
*Discuss Further
*Job Category
*Overall Rating
*Favorite Area
*Key Tech Focus
*Willing to Receive Updates?
Other Suggestions
Coming soon!